BioAge Labs is a biotechnology company focused on leveraging artificial intelligence and machine learning to unlock the biology of aging and develop therapeutics that can extend healthy lifespan
The company harnesses its proprietary platform to analyze vast amounts of biological data in order to identify and validate novel drug targets linked to aging-related diseases. Through its innovative research, BioAge aims to create effective therapies that not only treat age-associated conditions but also improve overall health and longevity in individuals.
Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group -- saw their stocks open for trading.
Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials.
